Neoplasms, Bladder
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer (NCT05072600) | Peking University First Hospital | 2021-12-07 |
| Study of ESG401 in Adults With Solid Tumors (NCT04892342) | Shanghai Escugen Biotechnology Co., Ltd | 2021-09-14 |
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. (NCT03335059) | Medical Enterprises Ltd. | 2019-04-04 |
Track Neoplasms, Bladder automatically
Every clearance here is in the API, with alerts when new ones post.